Baudax Bio, Inc. BXRXQ

Set alert

Price alert · BXRXQ

All alert types
0.00 USD 0.00 0.00%

At close · Oct 29

0.0001 Day range 0.0001
0.00001 52-week range 0.0001
YTD
+900.00%
1 year
+900.00%
Open
0.0001
Prev close
0.0001
Mkt cap
4.36K
Vol
1
Avg vol
0
EPS
773.40
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BXRXQ has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-17.41 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
FY 2017: -1.0×FY 2018: -0.9×FY 2019: -2.0×FY 2020: -0.2×FY 2021: -0.8×FY 2022: -0.0×
FY 2017 5y median -0.8× FY 2022
P/S 0.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 38.2×FY 2021: 15.5×FY 2022: 0.8×
FY 2017 5y median 0.8× FY 2022
P/B -0.0×
FY 2017: -1.0×FY 2018: -0.9×FY 2019: -3.9×FY 2020: -1.3×FY 2021: 1.3×FY 2022: -0.0×
FY 2017 5y median -0.9× FY 2022
P/FCF -0.0×
FY 2017: -1.4×FY 2018: -1.0×FY 2019: -1.3×FY 2020: -0.4×FY 2021: -0.3×FY 2022: -0.0×
FY 2017 5y median -0.4× FY 2022
EV/EBITDA -0.1×
FY 2017: -1.3×FY 2018: -1.0×FY 2019: -1.5×FY 2020: 0.0×FY 2021: -0.2×FY 2022: -0.1×
FY 2017 5y median -0.2× FY 2022
EV/Sales 2.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -3.6×FY 2021: 8.7×FY 2022: 2.3×
FY 2017 5y median 0.0× FY 2022
FCF Yield -2637.5%
FY 2017: -70.2%FY 2018: -99.6%FY 2019: -79.7%FY 2020: -237.6%FY 2021: -294.8%FY 2022: -2637.5%
FY 2017 5y median -237.6% FY 2022

Profitability

Gross Margin -452.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -251.3%FY 2021: -126.4%FY 2022: -452.3%
FY 2017 5y median -126.4% FY 2022
Operating Margin -4477.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -15169.6%FY 2021: -1759.8%FY 2022: -4477.0%
FY 2017 5y median -1759.8% FY 2022
Net Margin -4633.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -15436.1%FY 2021: -1830.5%FY 2022: -4633.2%
FY 2017 5y median -1830.5% FY 2022
ROE 242.5%
FY 2017: 97.8%FY 2018: 107.8%FY 2019: 194.7%FY 2020: 514.2%FY 2021: -149.5%FY 2022: 242.5%
FY 2017 5y median 194.7% FY 2022
ROIC 974.8%
FY 2017: 509.6%FY 2018: -600.6%FY 2019: -69.5%FY 2020: -144.9%FY 2021: -47.7%FY 2022: 974.8%
FY 2017 5y median -69.5% FY 2022
ROA -586.1%
FY 2017: -186.5%FY 2018: -210.3%FY 2019: -60.1%FY 2020: -110.7%FY 2021: -37.1%FY 2022: -586.1%
FY 2017 5y median -110.7% FY 2022

Growth (YoY)

Revenue 17.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 119.1%FY 2022: 17.5%
FY 2017 FY 2022
Operating Income -198.9%
FY 2017: 0.0%FY 2018: -20.4%FY 2019: 55.8%FY 2020: -130.0%FY 2021: 74.6%FY 2022: -198.9%
FY 2017 FY 2022
EPS (diluted) 50.9%
FY 2017: 0.0%FY 2018: -20.6%FY 2019: 57.1%FY 2020: -17.3%FY 2021: 93.7%FY 2022: 50.9%
FY 2017 FY 2022
Free Cash Flow 43.8%
FY 2017: 0.0%FY 2018: -41.8%FY 2019: 18.5%FY 2020: 13.3%FY 2021: -10.7%FY 2022: 43.8%
FY 2017 FY 2022

Financial Health

Current Ratio 0.3×
FY 2017: 0.1×FY 2018: 0.1×FY 2019: 2.6×FY 2020: 2.0×FY 2021: 1.5×FY 2022: 0.3×
FY 2017 5y median 1.5× FY 2022
Quick Ratio 0.3×
FY 2017: 0.1×FY 2018: 0.1×FY 2019: 2.6×FY 2020: 1.9×FY 2021: 1.2×FY 2022: 0.3×
FY 2017 5y median 1.2× FY 2022
Debt / Equity -0.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.0×FY 2020: -0.7×FY 2021: 0.6×FY 2022: -0.3×
FY 2017 5y median -0.0× FY 2022
Net Debt / EBITDA -0.1×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.5×FY 2020: 0.3×FY 2021: 0.1×FY 2022: -0.1×
FY 2017 5y median 0.1× FY 2022
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -55.0×FY 2021: -8.3×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31